Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05507151 · ClinicalTrials.gov registry record
Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
A clinical trial of Nonalcoholic Fatty Liver Disease, sponsored by West Virginia University.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT05507151 is a study of Nonalcoholic Fatty Liver Disease that is actively recruiting participants, run by West Virginia University. The registered enrollment target is 30 participants, below the 112-participant average among 9 other Nonalcoholic Fatty Liver Disease trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05507151, a study of Nonalcoholic Fatty Liver Disease, is actively recruiting participants, sponsored by West Virginia University.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Endoscopic weight loss procedures, also termed endoscopic sleeve gastroplasty (ESG), has been proposed as a non-surgical procedure for managing obesity and offers a standard weight loss approach. Realizing there is a knowledge gap in applying ESG to morbidly obese patients with NAFLD, the investigators propose studying the efficacy of weight control and functional outcomes of ESG. This prospective pilot study is aimed to study the safety profiles, quality of life, and changes and improvements in the anthropometric, metabolic, and biochemical changes in these patients.
Conditions Studied
Interventions
- PROCEDURE Endoscopic Sleeve Gastroplasty
Study Locations (1)
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-08-24 |
| Est. Completion | 2026-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05507151
The ClinicalTrials.gov registry entry for NCT05507151 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 112-participant average among 9 other Nonalcoholic Fatty Liver Disease trials with a reported enrollment target (73% lower). The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nonalcoholic Fatty Liver Disease appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic Sleeve Gastroplasty is the first listed.
NCT05507151 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.
Frequently Asked Questions
What is clinical trial NCT05507151 about?
NCT05507151 is a clinical study titled "Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis". Endoscopic weight loss procedures, also termed endoscopic sleeve gastroplasty (ESG), has been proposed as a non-surgical procedure for managing obesity and offers a standard weight loss approach. Realizing there is a knowledge gap in applying ESG to morbidly obese patients with NAFLD, the investigat...
What is the current status of trial NCT05507151?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2022-08-24. Estimated completion is 2026-05.
What conditions does trial NCT05507151 study?
This clinical trial studies the following conditions: Nonalcoholic Fatty Liver Disease.
What interventions are being tested in trial NCT05507151?
The interventions under investigation include: Endoscopic Sleeve Gastroplasty (PROCEDURE).
Who is sponsoring clinical trial NCT05507151?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05507151 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nonalcoholic Fatty Liver Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease
ACTIVE NOT RECRUITING
-
Phase 2b Study of GSK4532990 in Adults With NASH
ACTIVE NOT RECRUITING · Phase 2
-
Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)
COMPLETED · Phase 2
-
Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes
COMPLETED · Phase 3
-
Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease
COMPLETED
-
Dietary Treatment Study of Pediatric NAFLD
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.